Several clinicopathological factors including the gender and age of patients, tumor size, histological grade, tumor infiltration (T stage), lymphatic invasion (N stage), and TNM stage were enrolled to investigate the potential HJURP-associated factors in CCA (Table 2). This evidence concerns the gene HJURP and cholangiocarcinoma.